Playlist

Gurbanguly Berdimuhamedov Congratulates Amangozel Shaguliyeva on Her 85th Birthday

12 Aug. 06:03

Source

National Leader of the Turkmen people and Chairman of the Halk Maslahaty of Turkmenistan, Gurbanguly Berdimuhamedov, sent a congratulatory letter to Amangozel Shaguliyeva, Hero of Turkmenistan and People’s Poet, on her 85th birthday, TDH reports.

In the letter, he noted that the country's historical transformations and international achievements are widely reflected in the works of writers, poets, and journalists, with Shaguliyeva’s creativity playing a special role.

Berdimuhamedov emphasized that her poetry is regularly featured in the press, on television, and radio, earning her deep respect among the people. He also mentioned that her work was reflected in his book "The Meaning of My Life," where he highlighted her contributions to Turkmen literature and the country’s cultural and public life.

He wrote that her verses express profound love for the homeland, loyalty to ancestral traditions, the noble qualities of Turkmen women, and the importance of child upbringing.

The letter also pointed out that her 85th anniversary coincides with the grand celebration of the 30th anniversary of Turkmenistan’s permanent neutrality. In Turkmen tradition, the age of 85 is considered a symbol of wisdom, dignity, and maturity.

Amangozel Shaguliyeva has been awarded the title “Hero of Turkmenistan,” the honorary title “People’s Writer of Turkmenistan,” the Magtymguly International Prize, and numerous other state awards.

















US Scientists Develop Drug That Mimics Exercise Effects

Today in 10:05

Source

American researchers have initiated trials for a new pharmaceutical compound designated as ENV-308, designed to replicate the physiological effects of intensive physical training. Formulated in tablet form, the medication aims to trigger the body's metabolic responses similar to those experienced during exercise.

Scientists at Enveda utilized the Lac-Phe molecule as the core component for this development. Naturally produced by the body during vigorous exertion, this molecule transmits signals to the brain that suppress appetite and signal satiety.

Preclinical trials conducted on animal models demonstrated significant positive results. The tablets effectively reduced hunger levels and facilitated weight loss while entirely preserving existing muscle mass.

Researchers have successfully completed the first phase of clinical trials, confirming the safety of the drug for human use. Future studies will focus on evaluating the compound's impact on metabolism and exploring its potential combination with established therapeutics such as Ozempic.